Decision Diagnos Stock Price, News & Analysis
Company Description
Decision Diagnos (OTC Link: DECN) is a publicly traded pharmaceutical retailers company in the Healthcare sector. The company has a market capitalization of $35.8K.
DECN stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of DECN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Decision Diagnos (DECN) stock last traded at $0.0000. At a market capitalization of $35.8K, DECN is classified as a micro-cap stock with approximately 141.6M shares outstanding.
Latest News
Decision Diagnos has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include covid-19, fda approval. View all DECN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Decision Diagnos (DECN) currently stands at 100 shares, down 9.1% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Decision Diagnos (DECN) currently stands at 1000.0 days, up 4445.4% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
DECN Company Profile & Sector Positioning
Decision Diagnos (DECN) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DECN often look at related companies in the same sector, including Kiaro Hldgs (KIARF), Allstar Health Brands Inc (ALST), Health Advance I (HADV), Pineapple (PNPL), and Blum Holdings (BLMH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DECN's relative position within its industry.